Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings — India Imports 2023
Country-wise import data for HS 3004
$1.6B
Total Imports (2023)
70
Supplying Countries
Germany
Top Supplier
Country-Wise Import Data — 2023
| # | Country | Import Value (USD) | Share | Quantity |
|---|---|---|---|---|
| 1 | 🇩🇪 Germany | $346.7M | 21.8% | 2,535,802.25 |
| 2 | 🇩🇰 Denmark | $246.2M | 15.5% | 552,932.3 |
| 3 | 🇮🇹 Italy | $233.6M | 14.7% | 3,437,864.83 |
| 4 | 🇨🇭 Switzerland | $167.3M | 10.5% | 309,622.69 |
| 5 | 🇫🇷 France | $129.1M | 8.1% | 2,094,503.25 |
| 6 | 🇸🇪 Sweden | $92.3M | 5.8% | 917,916.14 |
| 7 | 🇧🇷 Brazil | $67.3M | 4.2% | 322,286.45 |
| 8 | 🇧🇪 Belgium | $41.7M | 2.6% | 311,933.99 |
| 9 | 🇺🇸 United States | $34.5M | 2.2% | 115,621.47 |
| 10 | 🇳🇱 Netherlands | $28.3M | 1.8% | 78,691.21 |
| 11 | 🇰🇷 South Korea | $25.7M | 1.6% | 152,749.54 |
| 12 | 🇦🇹 Austria | $22.5M | 1.4% | 768,866.52 |
| 13 | 🇨🇳 China | $19.0M | 1.2% | 253,876.15 |
| 14 | 🇮🇳 India | $18.2M | 1.1% | 1,366,170.15 |
| 15 | 🇯🇵 Japan | $16.2M | 1.0% | 4,947.66 |
| 16 | 🇸🇬 Singapore | $13.1M | 0.8% | 3,996.9 |
| 17 | 🇮🇪 Ireland | $11.2M | 0.7% | 43,338 |
| 18 | 🇮🇩 Indonesia | $11.2M | 0.7% | 64,379 |
| 19 | 🇬🇧 United Kingdom | $10.9M | 0.7% | 4,344.51 |
| 20 | 🇪🇸 Spain | $7.7M | 0.5% | 292,552 |
| 21 | 🇬🇷 Greece | $6.6M | 0.4% | 52,014.45 |
| 22 | 🇦🇺 Australia | $6.5M | 0.4% | 21,857.98 |
| 23 | 🇹🇷 Turkey | $6.0M | 0.4% | 62,440.67 |
| 24 | 🇲🇾 Malaysia | $6.0M | 0.4% | 125,817 |
| 25 | 🇵🇹 Portugal | $3.8M | 0.2% | 39,649.97 |
| 26 | 🇧🇬 Bulgaria | $2.5M | 0.2% | 25,181.22 |
| 27 | 🇮🇱 Israel | $1.9M | 0.1% | 4,158.86 |
| 28 | 🇷🇴 Romania | $1.6M | 0.1% | 99,289.13 |
| 29 | 🇵🇱 Poland | $1.4M | 0.1% | 22,433.38 |
| 30 | 🇱🇰 Sri Lanka | $1.3M | 0.1% | 71,912.68 |
| 31 | 🇦🇪 United Arab Emirates | $1.1M | 0.1% | 8,610.05 |
| 32 | 🇨🇿 Czech Republic | $1.0M | 0.1% | 4,694.12 |
| 33 | 🇨🇺 Cuba | $856K | 0.1% | 22 |
| 34 | 🇨🇦 Canada | $685K | 0.0% | 786 |
| 35 | 🇫🇮 Finland | $614K | 0.0% | 3,466.53 |
| 36 | 🇿🇦 South Africa | $503K | 0.0% | 525.73 |
| 37 | 🇸🇮 Slovenia | $443K | 0.0% | 528.77 |
| 38 | 🇭🇺 Hungary | $347K | 0.0% | 1,154.62 |
| 39 | 🇭🇷 Croatia | $291K | 0.0% | 500 |
| 40 | 🇲🇽 Mexico | $283K | 0.0% | 16,680.62 |
| 41 | 🇳🇿 New Zealand | $230K | 0.0% | 1,631.57 |
| 42 | 🇱🇻 Latvia | $161K | 0.0% | 56 |
| 43 | 🇷🇺 Russia | $140K | 0.0% | 285 |
| 44 | 🇹🇭 Thailand | $135K | 0.0% | 758 |
| 45 | 🇨🇾 Cyprus | $123K | 0.0% | 64 |
| 46 | 🇹🇱 Timor-Leste | $87K | 0.0% | 2 |
| 47 | 🇨🇷 Costa Rica | $61K | 0.0% | 6,473 |
| 48 | 🇦🇷 Argentina | $58K | 0.0% | 73 |
| 49 | 🇸🇰 Slovakia | $33K | 0.0% | 258.22 |
| 50 | 🇧🇩 Bangladesh | $33K | 0.0% | 399 |
| 51 | 🇱🇹 Lithuania | $28K | 0.0% | 26 |
| 52 | 🇭🇰 Hong Kong | $25K | 0.0% | 16 |
| 53 | 🇲🇹 Malta | $21K | 0.0% | 36 |
| 54 | 🇳🇴 Norway | $19K | 0.0% | 136.19 |
| 55 | 🇬🇪 Georgia | $17K | 0.0% | 151.3 |
| 56 | 🇻🇳 Vietnam | $14K | 0.0% | 4,491.91 |
| 57 | 🇩🇿 Algeria | $11K | 0.0% | 100.22 |
| 58 | 🇵🇭 Philippines | $8K | 0.0% | 30 |
| 59 | 🇶🇦 Qatar | $6K | 0.0% | 12 |
| 60 | 🇵🇸 Palestine | $6K | 0.0% | 679 |
| 61 | 🇳🇦 Namibia | $4K | 0.0% | 39.45 |
| 62 | 🇷🇸 Serbia | $4K | 0.0% | 31.61 |
| 63 | 🇴🇲 Oman | $1K | 0.0% | 28 |
| 64 | 🇵🇪 Peru | $533 | 0.0% | 22 |
| 65 | 🇨🇴 Colombia | $484 | 0.0% | 4.28 |
| 66 | 🇯🇴 Jordan | $337 | 0.0% | 4 |
| 67 | 🇳🇬 Nigeria | $205 | 0.0% | 1.81 |
| 68 | 🇲🇦 Morocco | $159 | 0.0% | 18 |
| 69 | 🇸🇳 Senegal | $73 | 0.0% | 10 |
| 70 | 🇧🇳 Brunei | $49 | 0.0% | 0.43 |
| Total | $1.6B | 100% | ||
← Back to Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings import overviewView export data for Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings →
India's Import Market for Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings
Explore sourcing opportunities and supplier data.
Contact XIMPEX